Whittemore Tingley
Technik-/Wissenschafts-/F&E-Leiter bei TENAYA THERAPEUTICS, INC.
Vermögen: 104 588 $ am 30.04.2024
Aktive Positionen von Whittemore Tingley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TENAYA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2018 | - |
Karriereverlauf von Whittemore Tingley
Ehemalige bekannte Positionen von Whittemore Tingley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | 01.09.2017 | 01.12.2018 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 | 01.09.2017 |
ROCHE HOLDING AG | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Whittemore Tingley
Brown University | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Schweiz | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
TENAYA THERAPEUTICS, INC. | Health Technology |
CYTOKINETICS, INCORPORATED | Health Technology |
ROCHE HOLDING AG | Health Technology |
Private Unternehmen | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Whittemore Tingley
- Erfahrung